NCT04318145Phase 2Terminated

Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects

Study sponsor: Palatin Technologies, Inc · PTN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-12-08Actual
Enrollment · participants15Actual
Source updated2025-12-15Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 55 participants (planned). After: 15 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 31 Mar 2022. After: 8 Dec 2023.

Recruitment status changed

Before: Recruiting. After: Terminated.

Check registry source